Rate My Professor Martin Punter

Punter's research specializations center on stroke medicine, with particular emphasis on venous stroke, ischaemic stroke syndromes such as pontine ischaemic stroke, intracerebral haemorrhage outcomes compared to ischaemic stroke, stroke reperfusion therapy including tenecteplase real-world data, sex differences in stroke therapy in New Zealand, uncommon causes of ischaemic stroke, cerebral venous thrombosis including dural arteriovenous fistulas and seizures, and stroke risks and characteristics in SARS-CoV-2 infected patients. His work features in multinational collaborative studies, including the RESTART randomised trial on antiplatelet therapy after intracerebral haemorrhage. Key publications include 'Tenecteplase real-world data: A three phase sequential comparison' (2023, co-authored with Anna Ranta et al.), 'Pontine ischaemic stroke syndromes' (2023), 'Sex differences in stroke reperfusion therapy in Aotearoa (New Zealand)' (2024), 'Pre-Hospital Telestroke vs Paramedic Scores to Accurately Identify Stroke Reperfusion Candidates: A Cluster Randomised Controlled Trial' (2022), 'SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group' (2021), 'Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study' (2020), 'Diagnosis and management of cerebral venous thrombosis' (2018), and 'Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial' (2019). Punter holds the position of Stroke Editor for Advances in Clinical Neuroscience and Rehabilitation and is a member of the Association of British Neurologists, the Stroke Society of Australasia, and the Overseas Trained Physicians Committee of the Royal Australasian College of Physicians.